{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:55:44Z","timestamp":1790024144352,"version":"4.0.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-0993-5","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T11:57:15Z","timestamp":1473940635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Oswald","family":"Moling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Piccin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Marinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Canova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Casini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Raffeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Binazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Vecchiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atto","family":"Billio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"993_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"28","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K. Hemophagocytic syndromes--an update. Blood Rev. 2014;28:135\u201342.","journal-title":"Blood Rev"},{"key":"993_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2014.00167","volume":"5","author":"E Sieni","year":"2014","unstructured":"Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, et al. Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning. Front Immunol. 2014;5:167. doi: 10.3389\/fimmu.2014.00167 .","journal-title":"Front Immunol"},{"key":"993_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/BOR.0b013e32834dd37e","volume":"24","author":"SW Canna","year":"2012","unstructured":"Canna SW, Behrens EM. Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes. Curr Opin Rheumatol. 2012;24:113\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"993_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","volume":"59","author":"SW Canna","year":"2012","unstructured":"Canna SW, Behrens EM. Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin North Am. 2012;59:329\u201344.","journal-title":"Pediatr Clin North Am"},{"key":"993_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"993_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13:289\u201398.","journal-title":"Genes Immun"},{"key":"993_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Ros\u00e1rio","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D\u2019Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.","journal-title":"BMC Med"},{"key":"993_CR8","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/art.38769","volume":"66","author":"S Dav\u00ec","year":"2014","unstructured":"Dav\u00ec S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66:2871\u201380.","journal-title":"Arthritis Rheumatol"},{"key":"993_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","volume":"36","author":"Y Shoenfeld","year":"2011","unstructured":"Shoenfeld Y, Agmon-Levin N. \u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36:4\u20138.","journal-title":"J Autoimmun"},{"key":"993_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12026-013-8401-3","volume":"56","author":"JW Cohen Tervaert","year":"2013","unstructured":"Cohen Tervaert JW, Kappel RM. Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld\u2019s syndrome). Immunol Res. 2013;56:293\u20138.","journal-title":"Immunol Res"},{"key":"993_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","volume":"47","author":"C Perricone","year":"2013","unstructured":"Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1\u201316.","journal-title":"J Autoimmun"},{"key":"993_CR12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0961203311429318","volume":"21","author":"Y Zafrir","year":"2012","unstructured":"Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y. Autoimmunity following hepatitis B vaccine as part of the spectrum of \u2018Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants\u2019 (ASIA): analysis of 93 cases. Lupus. 2012;21:146\u201352.","journal-title":"Lupus"},{"key":"993_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2362.2010.02389.x","volume":"41","author":"SD Hajdu","year":"2011","unstructured":"Hajdu SD, Agmon-Levin N, Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest. 2011;41:203\u201311.","journal-title":"Eur J Clin Invest"},{"key":"993_CR14","first-page":"185","volume":"10","author":"K Miyoshi","year":"1963","unstructured":"Miyoshi K, Miyaoka T, Kotani Y, Saijo K. \u201cSplenomegalia Hyperglobulinemica\u201d. Proposal of a new clinical syndrome. Tokushima J Exp Med. 1963;10:185\u201394.","journal-title":"Tokushima J Exp Med"},{"key":"993_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00000637-197911000-00010","volume":"3","author":"BF Uretsky","year":"1979","unstructured":"Uretsky BF, O\u2019Brien JJ, Courtiss EH, Becker MD. Augmentation mammaplasty associated with a severe systemic illness. Ann Plast Surg. 1979;3:445\u20137.","journal-title":"Ann Plast Surg"},{"key":"993_CR16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/ard.43.3.520","volume":"43","author":"Y Okano","year":"1984","unstructured":"Okano Y, Nishikai M, Sato A. Scleroderma, primary biliary cirrhosis, and Sj\u00f6gren\u2019s syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis. 1984;43:520\u20132.","journal-title":"Ann Rheum Dis"},{"key":"993_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-111-5-377","volume":"111","author":"J Varga","year":"1989","unstructured":"Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med. 1989;111:377\u201383.","journal-title":"Ann Intern Med"},{"key":"993_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.49.11.937","volume":"49","author":"W Kaiser","year":"1990","unstructured":"Kaiser W, Biesenbach G, Stuby U, Grafinger P, Zazgornik J. Human adjuvant disease: remission of silicone induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis. 1990;49:937\u20138.","journal-title":"Ann Rheum Dis"},{"key":"993_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2302\/kjm.43.79","volume":"43","author":"BO Shoaib","year":"1994","unstructured":"Shoaib BO, Patten BM, Calkins DS. Adjuvant breast disease: an evaluation of 100 symptomatic women with breast implants or silicone fluid injections. Keio J Med. 1994;43:79\u201387.","journal-title":"Keio J Med"},{"issue":"Suppl 1","key":"993_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0049-0172(94)90109-0","volume":"24","author":"B Freundlich","year":"1994","unstructured":"Freundlich B, Altman C, Snadorfi N, Greenberg M, Tomaszewski J. A profile of symptomatic patients with silicone breast implants: a Sj\u00f6grens-like syndrome. Semin Arthritis Rheum. 1994;24 Suppl 1:44\u201353.","journal-title":"Semin Arthritis Rheum"},{"key":"993_CR21","first-page":"1838","volume":"24","author":"LG Meier","year":"1997","unstructured":"Meier LG, Barthel HR, Seidl C. Development of polyarthritis after insertion of silicone breast implants followed by remission after implant removal in 2 HLA-identical sisters bearing rheumatoid arthritis susceptibility genes. J Rheumatol. 1997;24:1838\u201341.","journal-title":"J Rheumatol"},{"key":"993_CR22","doi-asserted-by":"crossref","unstructured":"Laing TJ, Schottenfeld D, Lacey Jr JV, Gillespie BW, Garabrant DH, Cooper BC, Heeringa SG, Alcser KH, Mayes MD. Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devices. Am J Epidemiol. 2001;154:610\u20137.","DOI":"10.1093\/aje\/154.7.610"},{"key":"993_CR23","first-page":"256","volume":"32","author":"RM Kappel","year":"2014","unstructured":"Kappel RM, Cohen Tervaert JW, Pruijn GJ. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) due to silicone implant incompatibility syndrome in three sisters. Clin Exp Rheumatol. 2014;32:256\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"993_CR24","first-page":"262","volume":"32","author":"G Al Aranji","year":"2014","unstructured":"Al Aranji G, White D, Solanki K. Scleroderma renal crisis following silicone breast implant rupture: a case report and review of the literature. Clin Exp Rheumatol. 2014;32:262\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"993_CR25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00000637-197910000-00005","volume":"3","author":"RE Zaworski","year":"1979","unstructured":"Zaworski RE, DerHagopian RP. Locally recurrent carcinoma after breast reconstruction. Ann Plast Surg. 1979;3:326\u20139.","journal-title":"Ann Plast Surg"},{"key":"993_CR26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archsurg.1985.01390290051008","volume":"120","author":"L Morgenstern","year":"1985","unstructured":"Morgenstern L, Gleischman SH, Michel SL, Rosenberg JE, Knight I, Goodman D. Relation of free silicone to human breast carcinoma. Arch Surg. 1985;120:573.","journal-title":"Arch Surg"},{"key":"993_CR27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000637-198803000-00007","volume":"20","author":"HG Bingham","year":"1988","unstructured":"Bingham HG, Copeland EM, Hackett R, Caffee HH. Breast cancer in a patient with silicone breast implants after 13 years. Ann Plast Surg. 1988;20:236\u20137.","journal-title":"Ann Plast Surg"},{"key":"993_CR28","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJM199506083322302","volume":"332","author":"H Bryant","year":"1995","unstructured":"Bryant H, Brasher P. Breast implants and breast cancer--reanalysis of a linkage study. N Engl J Med. 1995;332:1535\u20139.","journal-title":"N Engl J Med"},{"key":"993_CR29","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/92.21.1714","volume":"92","author":"NJ Nelson","year":"2000","unstructured":"Nelson NJ. Silicone breast implants not linked to breast cancer risk. J Natl Cancer Inst. 2000;92:1714\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"993_CR30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bjps.2007.03.017","volume":"60","author":"SA McIntosh","year":"2007","unstructured":"McIntosh SA, Horgan K. Breast cancer following augmentation mammoplasty \u2013 a review of its impact on prognosis and management. J Plast Reconstr Aesthet Surg. 2007;60:1127\u201335.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"993_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1477-7819-6-33","volume":"6","author":"Y Tanaka","year":"2008","unstructured":"Tanaka Y, Morishima I, Kikuchi K. Invasive micropapillary carcinomas arising 42 years after augmentation mammoplasty: a case report and literature review. World J Surg Oncol. 2008;6:33.","journal-title":"World J Surg Oncol"},{"key":"993_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10428190210189","volume":"43","author":"G Gaudet","year":"2002","unstructured":"Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma. 2002;43:115\u20139.","journal-title":"Leuk Lymphoma"},{"key":"993_CR33","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/1078-0432.CCR-12-0101","volume":"18","author":"MG Lechner","year":"2012","unstructured":"Lechner MG, Megiel C, Church CH, Angell TE, Russell SM, Sevell RB, et al. Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma. Clin Cancer Res. 2012;18:4549\u201359.","journal-title":"Clin Cancer Res"},{"key":"993_CR34","first-page":"2092","volume":"30","author":"FB Vasey","year":"2003","unstructured":"Vasey FB, Zarabadi SA, Seleznick M, Ricca L. Where there\u2019s smoke there\u2019s fire: the silicone breast implant controversy continues to flicker: a new disease that needs to be defined. J Rheumatol. 2003;30:2092\u20134.","journal-title":"J Rheumatol"},{"key":"993_CR35","unstructured":"Solomon G, Espinoza L, Silverman S. Breast implants and connective-tissue diseases. N Engl J Med. 1994;331:1231. author reply 1233-4. Erratum in: N Engl J Med 1995;332:199."},{"key":"993_CR36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/MDER.S49522","volume":"6","author":"AE Steiert","year":"2013","unstructured":"Steiert AE, Boyce M, Sorg H. Capsular contracture by silicone breast implants: possible causes, biocompatibility, and prophylactic strategies. Med Devices (Auckl). 2013;6:211\u20138.","journal-title":"Med Devices (Auckl)"},{"key":"993_CR37","unstructured":"Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 252\u20133."},{"key":"993_CR38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5858\/arpa.2010-0747-RS","volume":"136","author":"DE Orwat","year":"2012","unstructured":"Orwat DE, Batalis NI. Intravascular large B-cell lymphoma. Arch Pathol Lab Med. 2012;136:333\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"993_CR39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/theoncologist.11-5-496","volume":"11","author":"D Zuckerman","year":"2006","unstructured":"Zuckerman D, Seliem R, Hochberg E. Intravascular lymphoma: the oncologist\u2019s \u201cgreat imitator\u201d. Oncologist. 2006;11:496\u2013502.","journal-title":"Oncologist"},{"key":"993_CR40","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/cam4.269","volume":"3","author":"E Fonkem","year":"2014","unstructured":"Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3:1010\u201324.","journal-title":"Cancer Med"},{"key":"993_CR41","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/1097-0142(19930515)71:10<3156::AID-CNCR2820711043>3.0.CO;2-O","volume":"71","author":"J Glass","year":"1993","unstructured":"Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis. A systemic disease with neurologic manifestations. Cancer. 1993;71:3156\u201364.","journal-title":"Cancer"},{"key":"993_CR42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/1042819021000055291","volume":"44","author":"TS Davis","year":"2003","unstructured":"Davis TS. Intravascular lymphoma presenting with cauda equina syndrome: treated with CHOP and rituxan. Leuk Lymphoma. 2003;44:887\u20138.","journal-title":"Leuk Lymphoma"},{"key":"993_CR43","doi-asserted-by":"crossref","unstructured":"Abuzinadah A, Almalik Y, Shabani-Rad MT, Ho CH, George D, Alant J, Zochodne D. Cauda equina syndrome secondary to intravascular lymphoma. Neurol Clin Pract. 2012;2:158\u201361.","DOI":"10.1212\/CPJ.0b013e31825a61bb"},{"key":"993_CR44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/practneurol-2014-001048","volume":"15","author":"NT Colchester","year":"2015","unstructured":"Colchester NT, Barker CS, Jogai S, Katifi HA. Cauda equina syndrome due to intravascular lymphoma: diagnosis by nasal biopsy. Pract Neurol. 2015;15:210\u20133.","journal-title":"Pract Neurol"},{"key":"993_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hon.2140","volume":"33","author":"C Colavolpe","year":"2014","unstructured":"Colavolpe C, Ebbo M, Trousse D, Khibri H, Franques J, Chetaille B, et al. FDG-PET\/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature. Hematol Oncol. 2014;33:99\u2013109.","journal-title":"Hematol Oncol"},{"key":"993_CR46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00277-010-1101-3","volume":"90","author":"K Matsue","year":"2011","unstructured":"Matsue K, Asada N, Odawara J, Aoki T, Kimura S, Iwama K, et al. Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. Ann Hematol. 2011;90:417\u201321.","journal-title":"Ann Hematol"},{"key":"993_CR47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00277-011-1333-x","volume":"91","author":"T Nakazato","year":"2012","unstructured":"Nakazato T, Sanada Y, Mihara A, Ito C, Aisa Y, Nakamura N. PET-negative pulmonary intravascular large B cell lymphoma diagnosed by a random transbronchial lung biopsy. Ann Hematol. 2012;91:811\u20132.","journal-title":"Ann Hematol"},{"key":"993_CR48","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2169\/internalmedicine.49.3986","volume":"49","author":"N Kaku","year":"2010","unstructured":"Kaku N, Seki M, Doi S, Hayashi T, Imanishi D, Imamura Y, et al. A case of intravascular large B-cell lymphoma (IVLBCL) with no abnormal findings on chest computed tomography diagnosed by random transbronchial lung biopsy. Intern Med. 2010;49:2697\u2013701.","journal-title":"Intern Med"},{"key":"993_CR49","doi-asserted-by":"crossref","first-page":"e78730","DOI":"10.1371\/journal.pone.0078730","volume":"8","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Oda M, Kuroda Y, Katayama Y, Okikawa Y, Masunari T, et al. Clinical significance of sIL-2R levels in B-cell lymphomas. PLoS One. 2013;8:e78730.","journal-title":"PLoS One"},{"key":"993_CR50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00277-011-1239-7","volume":"91","author":"C Tabata","year":"2012","unstructured":"Tabata C, Tabata R. Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome. Ann Hematol. 2012;91:63\u201371.","journal-title":"Ann Hematol"},{"key":"993_CR51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","volume":"93","author":"T Tsuji","year":"2014","unstructured":"Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014;93:821\u20136.","journal-title":"Ann Hematol"},{"key":"993_CR52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0046-8177(96)90379-2","volume":"27","author":"P Chu","year":"1996","unstructured":"Chu P, Costa J, Lachman MF. Angiotropic large cell lymphoma presenting as primary adrenal insufficiency. Hum Pathol. 1996;27:209\u201311.","journal-title":"Hum Pathol"},{"key":"993_CR53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2169\/internalmedicine.42.609","volume":"42","author":"A Fukushima","year":"2003","unstructured":"Fukushima A, Okada Y, Tanikawa T, Onaka T, Tanaka A, Higashi T, et al. Primary bilateral adrenal intravascular large B-cell lymphoma associated with adrenal failure. Intern Med. 2003;42:609\u201314.","journal-title":"Intern Med"},{"key":"993_CR54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajh.20627","volume":"81","author":"F Askarian","year":"2006","unstructured":"Askarian F, Xu D. Adrenal enlargement and insufficiency: a common presentation of intravascular large B-cell lymphoma. Am J Hematol. 2006;81:411\u20133.","journal-title":"Am J Hematol"},{"key":"993_CR55","doi-asserted-by":"publisher","unstructured":"Takahashi Y, Iida K, Hino Y, Ohara T, Kurahashi T, Tashiro T, et al. Silent intravascular lymphoma initially manifesting as a unilateral adrenal incidentaloma. Case Rep Med. 2012;2012(849285):5. doi: 10.1155\/2012\/849285 .","DOI":"10.1155\/2012\/849285"},{"key":"993_CR56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clinthera.2006.05.002","volume":"28","author":"O Moling","year":"2006","unstructured":"Moling O, Cairon E, Rimenti G, Rizza F, Prister\u00e1 R, Mian P. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther. 2006;28:755\u201360.","journal-title":"Clin Ther"},{"key":"993_CR57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/clin.1998.4532","volume":"87","author":"AH McDonald","year":"1998","unstructured":"McDonald AH, Weir K, Schneider M, Gudenkauf L, Sanger JR. Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB\/cAnPt mice. Clin Immunol Immunopathol. 1998;87:248\u201355.","journal-title":"Clin Immunol Immunopathol"},{"key":"993_CR58","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMra1100030","volume":"365","author":"JH Cho","year":"2011","unstructured":"Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 2011;365:1612\u201323.","journal-title":"N Engl J Med"},{"key":"993_CR59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/44853","volume":"401","author":"The MHC sequencing consortium","year":"1999","unstructured":"The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature. 1999;401:921\u20133.","journal-title":"Nature"},{"key":"993_CR60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/jhg.2008.5","volume":"54","author":"T Shiina","year":"2009","unstructured":"Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009;54:15\u201339.","journal-title":"J Hum Genet"},{"key":"993_CR61","doi-asserted-by":"publisher","unstructured":"Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008;4(4):e1000024. doi: 10.1371\/journal.pgen.1000024 .","DOI":"10.1371\/journal.pgen.1000024"},{"key":"993_CR62","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/00006534-199512000-00001","volume":"96","author":"VL Young","year":"1995","unstructured":"Young VL, Nemecek JR, Schwartz BD, Phelan DL, Schorr MW. HLA typing in women with breast implants. Plast Reconstr Surg. 1995;96:1497\u2013519.","journal-title":"Plast Reconstr Surg"},{"key":"993_CR63","first-page":"1872","volume":"22","author":"JH Morse","year":"1995","unstructured":"Morse JH, Fotino M, Zhang Y, Flaster ER, Peebles CL, Spiera H. Position 26 of the first domain of the HLA-DQB1 allele in post-silicone implant scleroderma. J Rheumatol. 1995;22:1872\u20135.","journal-title":"J Rheumatol"},{"key":"993_CR64","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1002\/art.20587","volume":"50","author":"T O\u2019Hanlon","year":"2004","unstructured":"O\u2019Hanlon T, Koneru B, Bayat E, Love L, Targoff I, Malley J, et al. Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum. 2004;50:3646\u201350.","journal-title":"Arthritis Rheum"},{"key":"993_CR65","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1002\/jps.24573","volume":"104","author":"CF Chisholm","year":"2015","unstructured":"Chisholm CF, Nguyen BH, Soucie KR, Torres RM, Carpenter JF, Randolph TW. In vivo analysis of the potency of silicone oil microdroplets as immunological adjuvants in protein formulations. Pharm Sci. 2015;104:3681\u201390.","journal-title":"Pharm Sci"},{"key":"993_CR66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/08820139509066849","volume":"24","author":"JO Naim","year":"1995","unstructured":"Naim JO, Ippolito KM, Lanzafame RJ. The effect of molecular weight and gel preparation on humoral adjuvancy of silicone oils and silicone gels. Immunol Invest. 1995;24:537\u201347.","journal-title":"Immunol Invest"},{"key":"993_CR67","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/(SICI)1097-4636(19971215)37:4<534::AID-JBM12>3.0.CO;2-8","volume":"37","author":"JO Naim","year":"1997","unstructured":"Naim JO, Ippolito KM, van Oss CJ. Adjuvancy effect of different types of silicone gel. J Biomed Mater Res. 1997;37:534\u20138.","journal-title":"J Biomed Mater Res"},{"key":"993_CR68","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/CDLI.7.3.366-370.2000","volume":"7","author":"JO Naim","year":"2000","unstructured":"Naim JO, Satoh M, Buehner NA, Ippolito KM, Yoshida H, Nusz D, et al. Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice. Clin Diagn Lab Immunol. 2000;7:366\u201370.","journal-title":"Clin Diagn Lab Immunol"},{"key":"993_CR69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2172-3-6","volume":"3","author":"P Iribarren","year":"2002","unstructured":"Iribarren P, Correa SG, Sodero N, Riera CM. Activation of macrophages by silicones: phenotype and production of oxidant metabolites. BMC Immunol. 2002;3:6.","journal-title":"BMC Immunol"},{"key":"993_CR70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imbio.2011.08.003","volume":"217","author":"O S\u00e1nchez","year":"2012","unstructured":"S\u00e1nchez O, Rodr\u00edguez-Sureda V, Dom\u00ednguez C, Fern\u00e1ndez-Figueras T, Vilches A, Llurba E, et al. Study of biomaterial-induced macrophage activation, cell-mediated immune response and molecular oxidative damage in patients with dermal bioimplants. Immunobiology. 2012;217:44\u201353.","journal-title":"Immunobiology"},{"key":"993_CR71","doi-asserted-by":"crossref","unstructured":"Zhou J, Hao G, Weng H, Tsai YT, Baker DW, Sun X, Tang L. In vivo evaluation of medical device-associated inflammation using a macrophage-specific positron emission tomography (PET) imaging probe. Bioorg Med Chem Lett. 2013;23:2044\u20137.","DOI":"10.1016\/j.bmcl.2013.02.004"},{"key":"993_CR72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00000637-199705000-00001","volume":"38","author":"WH Beekman","year":"1997","unstructured":"Beekman WH, Feitz R, van Diest PJ, Hage JJ. Migration of silicone through the fibrous capsules of mammary prostheses. Ann Plast Surg. 1997;38:441\u20135.","journal-title":"Ann Plast Surg"},{"key":"993_CR73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archderm.1993.01680220075018","volume":"129","author":"RM Silver","year":"1993","unstructured":"Silver RM, Sahn EE, Allen JA, Sahn S, Greene W, Maize JC, et al. Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol. 1993;129:63\u20138.","journal-title":"Arch Dermatol"},{"key":"993_CR74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006534-199503000-00012","volume":"95","author":"WB Greene","year":"1995","unstructured":"Greene WB, Raso DS, Walsh LG, Harley RA, Silver RM. Electron probe microanalysis of silicon and the role of the macrophage in proximal (capsule) and distant sites in augmentation mammaplasty patients. Plast Reconstr Surg. 1995;95:513\u20139.","journal-title":"Plast Reconstr Surg"},{"key":"993_CR75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jcp.51.7.493","volume":"51","author":"PJ Diest van","year":"1998","unstructured":"van Diest PJ, Beekman WH, Hage JJ. Pathology of silicone leakage from breast implants. J Clin Pathol. 1998;51:493\u20137.","journal-title":"J Clin Pathol"},{"key":"993_CR76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0961203311430970","volume":"21","author":"LJ Jara","year":"2012","unstructured":"Jara LJ, Medina G, G\u00f3mez-Ba\u00f1uelos E, Saavedra MA, Vera-Lastra O. Still\u2019s disease, lupus-like syndrome, and silicone breast implants. A case of \u2018ASIA\u2019 (Shoenfeld\u2019s syndrome). Lupus. 2012;21:140\u20135.","journal-title":"Lupus"},{"key":"993_CR77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01450969","volume":"17","author":"I Katayama","year":"1998","unstructured":"Katayama I, Umeda T, Nishioka K. Adult Still\u2019s-disease-like illness in a patient with silicone breast implants. Clin Rheumatol. 1998;17:81\u20132.","journal-title":"Clin Rheumatol"},{"key":"993_CR78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002960000088","volume":"20","author":"E Cr\u00e9tel","year":"2001","unstructured":"Cr\u00e9tel E, Richard MA, Jean R, Durand JM. Still\u2019s-like disease, breast prosthesis, and collagen implants. Rheumatol Int. 2001;20:129\u201331.","journal-title":"Rheumatol Int"},{"key":"993_CR79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00000441-200402000-00010","volume":"327","author":"M Montalto","year":"2004","unstructured":"Montalto M, Vastola M, Santoro L, La Regina M, Curigliano V, Manna R, et al. Systemic inflammatory diseases and silicone breast prostheses: report of a case of adult still disease and review of the literature. Am J Med Sci. 2004;327:102\u20134.","journal-title":"Am J Med Sci"},{"key":"993_CR80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.20452\/pamw.308","volume":"118","author":"A B\u0142asiak","year":"2008","unstructured":"B\u0142asiak A, B\u0142achowicz A, Gietka A, Rell-Bakalarska M, Franek E. Still\u2019s disease in patient with silicone breast implants: case report. Pol Arch Med Wewn. 2008;118:65\u20137.","journal-title":"Pol Arch Med Wewn"},{"key":"993_CR81","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00296-008-0825-z","volume":"29","author":"FH F\u00e9lix","year":"2009","unstructured":"F\u00e9lix FH, Leal LK, Fontenele JB. Cloak and dagger: the case for adult onset Still disease and hemophagocytic lymphohistiocytosis. Rheumatol Int. 2009;29:973\u20134.","journal-title":"Rheumatol Int"},{"key":"993_CR82","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/art.34514","volume":"64","author":"SJ Lee","year":"2012","unstructured":"Lee SJ, Cho YN, Kim TJ, Park SC, Park DJ, Jin HM, et al. Natural killer T cell deficiency in active adult-onset Still\u2019s disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells. Arthritis Rheum. 2012;64:2868\u201377.","journal-title":"Arthritis Rheum"},{"key":"993_CR83","first-page":"265","volume":"6","author":"E Khamaganova","year":"2001","unstructured":"Khamaganova E, Aleschenko S, Murashova L, Zaretskaya Y. Immunogenetic factors of predisposition to blood malignancies in russian population. Russ J Immunol. 2001;6:265\u201370.","journal-title":"Russ J Immunol"},{"key":"993_CR84","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12185-008-0040-4","volume":"87","author":"HB Choi","year":"2008","unstructured":"Choi HB, Roh SY, Choi EJ, Yoon HY, Kim SY, Hong YS, et al. Association of HLA alleles with non-Hodgkin\u2019s lymphoma in Korean population. Int J Hematol. 2008;87:203\u20139.","journal-title":"Int J Hematol"},{"key":"993_CR85","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1523-1747.ep12363352","volume":"107","author":"CM Jackow","year":"1996","unstructured":"Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic M. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107:373\u20136.","journal-title":"J Invest Dermatol"},{"key":"993_CR86","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1046\/j.1365-2133.2001.04496.x","volume":"145","author":"E Hodak","year":"2001","unstructured":"Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br J Dermatol. 2001;145:974\u201380.","journal-title":"Br J Dermatol"},{"key":"993_CR87","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2003.12.052","volume":"52","author":"E Hodak","year":"2005","unstructured":"Hodak E, Klein T, Gabay B, Ben-Amitai D, Bergman R, Gdalevich M, et al. Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system. J Am Acad Dermatol. 2005;52:393\u2013402.","journal-title":"J Am Acad Dermatol"},{"key":"993_CR88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2340\/00015555-0254","volume":"87","author":"C Vassallo","year":"2007","unstructured":"Vassallo C, Brazzelli V, Cestone E, Castello M, Ciocca O, Borroni RG, et al. Mycosis fungoides in childhood: description and study of two siblings. Acta Derm Venereol. 2007;87:529\u201332.","journal-title":"Acta Derm Venereol"},{"key":"993_CR89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.arcmed.2011.06.003","volume":"42","author":"F U\u00e7ar","year":"2011","unstructured":"U\u00e7ar F, S\u00f6nmez M, Erkut N, Balc\u0131 M, Y\u00fccel B, Y\u0131lmaz M, et al. Relation of HLA-A, -B, -DRB1 alleles and haplotypes in patients with acute leukemia: a case control study. Arch Med Res. 2011;42:305\u201310.","journal-title":"Arch Med Res"},{"key":"993_CR90","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2141.2002.03926.x","volume":"119","author":"I Theodorou","year":"2002","unstructured":"Theodorou I, Abel L, Mauro F, Duprey B, Magnac C, Payelle-Brogard B, et al. High occurence of DRB1 11 in chronic lymphocytic leukaemia families. Br J Haematol. 2002;119:713\u20135.","journal-title":"Br J Haematol"},{"key":"993_CR91","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjh.12956","volume":"166","author":"E Arons","year":"2014","unstructured":"Arons E, Adams S, Venzon DJ, Pastan I, Kreitman RJ. Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome. Br J Haematol. 2014;166:729\u201338.","journal-title":"Br J Haematol"},{"key":"993_CR92","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.humimm.2004.08.183","volume":"65","author":"V Re De","year":"2004","unstructured":"De Re V, Caggiari L, Talamini R, Crovatto M, De Vita S, Mazzaro C, et al. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Hum Immunol. 2004;65:1397\u2013404.","journal-title":"Hum Immunol"},{"key":"993_CR93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/ker335","volume":"51","author":"L Beretta","year":"2012","unstructured":"Beretta L, Rueda B, Marchini M, Santaniello A, Sime\u00f3n CP, Fonollosa V, et al. Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology (Oxford). 2012;51:52\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"993_CR94","doi-asserted-by":"publisher","unstructured":"Azzouz DF, Rak JM, Fajardy I, Allanore Y, Tiev KP, Farge-Bancel D, et al. Comparing HLA shared epitopes in French Caucasian patients with scleroderma. PLoS One. 2012;7(5):e36870. doi: 10.1371\/journal.pone.0036870 .","DOI":"10.1371\/journal.pone.0036870"},{"key":"993_CR95","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M, Liu X, Ji J, F\u00f6rsti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol. 2014;25:2025\u201330.","journal-title":"Ann Oncol"},{"key":"993_CR96","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s12032-011-0022-x","volume":"29","author":"N Suvajdzic","year":"2012","unstructured":"Suvajdzic N, Djurdjevic P, Todorovic M, Perunicic M, Stojanovi\u0107 R, Novkovic A, et al. Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases. Med Oncol. 2012;29:2207\u201311.","journal-title":"Med Oncol"},{"key":"993_CR97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2177\/jsci.37.111","volume":"37","author":"Y Takamine","year":"2014","unstructured":"Takamine Y, Ikumi N, Onoe H, Hayase M, Nagasawa Y, Sakagami M, et al. Diagnostic value of brain biopsy in intravascular large B-cell lymphoma mimicking progressive multifocal leukoencephalopathy: case report. Nihon Rinsho Meneki Gakkai Kaishi. 2014;37:111\u20135. Japanese.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"993_CR98","doi-asserted-by":"publisher","unstructured":"Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185. doi: 10.1155\/2014\/149185 .","DOI":"10.1155\/2014\/149185"},{"key":"993_CR99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.clbc.2011.03.020","volume":"11","author":"D Lazzeri","year":"2011","unstructured":"Lazzeri D, Agostini T, Bocci G, Giannotti G, Fanelli G, Naccarato AG, et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer. 2011;11:283\u201396.","journal-title":"Clin Breast Cancer"},{"key":"993_CR100","first-page":"1631","volume":"6","author":"EV George","year":"2013","unstructured":"George EV, Pharm J, Houston C, Al-Quran S, Brian G, Dong H, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol. 2013;6:1631\u201342.","journal-title":"Int J Clin Exp Pathol"},{"key":"993_CR101","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/1090820X14539503","volume":"34","author":"AM Hart","year":"2014","unstructured":"Hart AM, Lechowicz MJ, Peters KK, Holden J, Carlson GW. Breast implant-associated anaplastic large cell lymphoma: report of 2 cases and review of the literature. Aesthet Surg J. 2014;34:884\u201394.","journal-title":"Aesthet Surg J"},{"key":"993_CR102","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3324\/haematol.2010.026237","volume":"95","author":"PA Thompson","year":"2010","unstructured":"Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010;95:1977\u20139.","journal-title":"Haematologica"},{"key":"993_CR103","doi-asserted-by":"publisher","unstructured":"Aivaliotis IL, Pateras IS, Papaioannou M, Glytsou C, Kontzoglou K, Johnson EO, et al. How do cytokines trigger genomic instability? J Biomed Biotechnol. 2012;2013:536761. doi: 10.1155\/2012\/536761 .","DOI":"10.1155\/2012\/536761"},{"key":"993_CR104","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","volume":"41","author":"DR Hodge","year":"2005","unstructured":"Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005;41:2502\u201312.","journal-title":"Eur J Cancer"},{"key":"993_CR105","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2217\/imt.11.113","volume":"3","author":"DB Lowe","year":"2011","unstructured":"Lowe DB, Storkus WJ. Chronic inflammation and immunologic-based constraints in malignant disease. Immunotherapy. 2011;3:1265\u201374.","journal-title":"Immunotherapy"},{"key":"993_CR106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","volume":"24","author":"E Baecklund","year":"2014","unstructured":"Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces? Semin Cancer Biol. 2014;24:61\u201370.","journal-title":"Semin Cancer Biol"},{"key":"993_CR107","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","volume":"118","author":"K Zhang","year":"2011","unstructured":"Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118:5794\u20138.","journal-title":"Blood"},{"key":"993_CR108","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","volume":"7","author":"J Villanueva","year":"2005","unstructured":"Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005;7:R30\u20137.","journal-title":"Arthritis Res Ther"},{"key":"993_CR109","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","volume":"142","author":"AA Grom","year":"2003","unstructured":"Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003;142:292\u20136.","journal-title":"J Pediatr"},{"key":"993_CR110","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","volume":"58","author":"K Zhang","year":"2008","unstructured":"Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum. 2008;58:2892\u20136.","journal-title":"Arthritis Rheum"},{"key":"993_CR111","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","volume":"49","author":"SJ Vastert","year":"2010","unstructured":"Vastert SJ, van Wijk R, D\u2019Urbano LE, de Vooght KM, de Jager W, Ravelli A, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49:441\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"993_CR112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","volume":"42","author":"NM Wulffraat","year":"2003","unstructured":"Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford). 2003;42:375\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"993_CR113","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","volume":"58","author":"MM Hazen","year":"2008","unstructured":"Hazen MM, Woodward AL, Hofmann I, Degar BA, Grom A, Filipovich AH, et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum. 2008;58:567\u201370.","journal-title":"Arthritis Rheum"},{"key":"993_CR114","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/cncr.22718","volume":"109","author":"S Cannella","year":"2007","unstructured":"Cannella S, Santoro A, Bruno G, Pillon M, Mussolin L, Mangili G, et al. Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma. Cancer. 2007;109:2566\u201371.","journal-title":"Cancer"},{"key":"993_CR115","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1097\/MPH.0000000000000073","volume":"36","author":"B Ciambotti","year":"2014","unstructured":"Ciambotti B, Mussolin L, d\u2019Amore ES, Pillon M, Sieni E, Coniglio ML, et al. Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma. J Pediatr Hematol Oncol. 2014;36:e359\u201365.","journal-title":"J Pediatr Hematol Oncol"},{"key":"993_CR116","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1073\/pnas.0903815106","volume":"106","author":"J Chia","year":"2009","unstructured":"Chia J, Yeo KP, Whisstock JC, Dunstone MA, Trapani JA, Voskoboinik I. Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc Natl Acad Sci U S A. 2009;106:9809\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR117","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1073\/pnas.0809008106","volume":"106","author":"P Bolitho","year":"2009","unstructured":"Bolitho P, Street SE, Westwood JA, Edelmann W, Macgregor D, Waring P, et al. Perforin-mediated suppression of B-cell lymphoma. Proc Natl Acad Sci U S A. 2009;106:2723\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR118","doi-asserted-by":"crossref","first-page":"e24185","DOI":"10.4161\/onci.24185","volume":"2","author":"JA Trapani","year":"2013","unstructured":"Trapani JA, Thia KY, Andrews M, Davis ID, Gedye C, Parente P, et al. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology. 2013;2:e24185.","journal-title":"Oncoimmunology"},{"key":"993_CR119","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2007-02-072850","volume":"110","author":"I Voskoboinik","year":"2007","unstructured":"Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, Darcy PK, et al. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood. 2007;110:1184\u201390.","journal-title":"Blood"},{"key":"993_CR120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood-2010-12-324533","volume":"118","author":"JE Lykens","year":"2011","unstructured":"Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB. Perforin is a critical physiologic regulator of T-cell activation. Blood. 2011;118:618\u201326.","journal-title":"Blood"},{"key":"993_CR121","doi-asserted-by":"publisher","unstructured":"Voskoboinik I, Trapani JA. Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function. Front Immunol. 2013;4:441. doi: 10.3389\/fimmu.2013.00441 .","DOI":"10.3389\/fimmu.2013.00441"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-0993-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:03:15Z","timestamp":1749582195000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-0993-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-0993-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]},"article-number":"254"}}